We are monitoring the impact of COVID-19 & Recession alarm on North America Epigenetics Market Get in touch with us for detailed analysis Know More
Share on

North America Epigenetics Market Research Report – Segmented By Product, KITS, Reagents, Research Area, Country (the United States, Canada and Rest of North America) - Industry Analysis, Share, Size, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1882
Pages: 145

North America Epigenetics Market Size (2022 to 2027)

The North American Epigenetics Market size was estimated to be USD 233.37 million in 2022 and is predicted to reach USD 426.18 million by 2027, growing at a CAGR of 12.8 % during the forecast period.

Rising cancer prevalence, and increased research and development activities, and growing applications in Epigenetics are majorly promoting the growth rate of the North American epigenetics market.  Also, the financing for epigenetics research and developing uses of epigenetics in non-oncology illnesses contribute to the market growth. Moreover, Cancer is the second most common cause of mortality in the United States, accounting for almost one out of every four fatalities. 

In the coming years, the expanding application areas of epigenetics in non-oncology illnesses, customized medicine, and target treatment are likely to create potential possibilities for market participants. Also, increase in the risk of cardiovascular diseases and an increase in the investments in research and development practices. 

The market expansion is hampered by the high cost of instruments, a scarcity of skilled specialists. Also, the scarcity and lack of financing plans and awareness about epigenetics impede market growth.

Impact of COVID-19 on the North American epigenetics market:

COVID-19 illness is shown to be the most severe in those aged 65 and up who have pre-existing chronic diseases. This is nonexperimental observational research that looks at the results of COVID-19 in different patient groups. 

In the COVID-19 pandemic, epigenetics has played a critical role in the inflexibility of symptoms. Precision medicine is committed to a large rise in protecting the epigenetic variability in SARS-Cov-2 infection, with efforts focused on recognizing and promoting efficient pharma strategies.

The symptoms and severity of COVID-19 disease are both influenced by epigenetic mechanisms. The structure and anatomy of SARS-Cov-2, as well as other illnesses, have been identified. Researchers and physicians must incorporate epigenetic processes to create reliable prescriptions for global well-being to succeed in illness prevention in the long run.

This research report on the North America Epigenetics Market has been segmented & sub-segmented into the following categories:

By Product: 

  • Enzymes
  • Instruments & Consumable
  • KITS
  • Reagents

By Research Area: 

  • Developmental Biology
  • Oncology
  • Drug Delivery

By Enzymes: 

  • DNA-Modifying Enzymes
  • Protein-Modifying Enzymes
  • RNA-Modifying Enzymes

By Instruments & Consumables: 

  • Mass Spectrometers
  • Next-Generation Sequencers
  • qPCR
  • Sonicators

By KITS:

  • Bisulfite Conversion KITS
  • Chip-Sequence KITS
  • RNA Sequencing KITS
  • Whole-Genome Amplification KITS
  • 5-HMC and 5-MC Analysis KITS

By Reagents:

  • Antibodies
  • Buffers
  • Histones
  • Magnetic Beads
  • Primers

By Country: 

  • The U.S.
  • Canada
  • Rest of North America

Geographically, North America dominated the global market in 2019 due to its advanced technology and significant presence.

The U.S. Epigenetics Market is estimated to account for the most significant share in the North American epigenetics market during the forecast period. Y-O-Y growth in cancer incidence is majorly accelerating the epigenetics market in the United States. In addition, enlarging epigenetics applications in non-oncology diseases, personalized medicine, and target therapy are further anticipated to boost the market's growth rate. 

The Canadian epigenetics market is predicted to be another lucrative regional market in the North American market during the forecast period. The increasing obesity population, growing research on oncology diseases, and increasing collaborations between research institutes, biotechnology, and biopharmaceutical companies are estimated to support Canada's market growth. 

KEY MARKET PLAYERS:

A few of the notable companies playing a leading role in the North America epigenetics market are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc., and Zymo Research Corporation.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Enzymes                  

                                                5.1.2.1 DNA-Modifying Enzymes              

                                                5.1.2.2 Protein-Modifying Enzymes        

                                                5.1.2.3 RNA-Modifying Enzymes              

                                5.1.3 Instruments & Consumables                           

                                                5.1.3.1 Mass Spectrometers       

                                                5.1.3.2 Next-Generation Sequencers     

                                                5.1.3.3 QPCR     

                                                5.1.3.4 Sonicators            

                                                5.1.3.5 Others   

                                5.1.4 KITS                            

                                                5.1.4.1 Bisulfite Conversion KITS               

                                                5.1.4.2 Chip-Sequence KITS        

                                                5.1.4.3 RNA Sequencing KITS     

                                                5.1.4.4 Whole-Genome Amplification KITS          

                                                5.1.4.5 5-HMC and 5-MC Analysis KITS   

                                                5.1.4.6 Others   

                                5.1.5 Reagents                 

                                                5.1.5.1 Antibodies           

                                                5.1.5.2  buffers 

                                                5.1.5.3 Histones               

                                                5.1.5.4 Magnetic Beads

                                                5.1.5.5 Primers

                                                5.1.5.6 Others   

                                5.1.6  Y-o-Y Growth Analysis, By Product                              

                                5.1.7 Market Attractiveness Analysis, By Product                             

                                5.1.8  Market Share Analysis, By Product                              

                5.2 Research Area                                           

                                5.2.1 Introduction                           

                                5.2.2 Developmental Biology                     

                                5.2.3 Oncology                 

                                5.2.4 Drug Delivery                         

                                5.2.5 Y-o-Y Growth Analysis, By Research Area                  

                                5.2.6 Market Attractiveness Analysis, By Research Area                

                                5.2.7 Market Share Analysis, By Research Area                  

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Research Area             

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Research Area             

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Research Area             

                6.2 United States                                            

                6.3 Canada                                         

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Abcam plc.                                  

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Illumina, Inc.                                              

                8.3 QIAGEN N.V.                                             

                8.4 Merck & Co.                                               

                8.5 New England Biolabs, Inc.                                    

                8.6 Zymo Research Corporation                                

                8.7 Sigma-Aldrich Corporation                                   

                8.8 Thermo Fisher Scientific, Inc.                                              

                8.9 Active Motif                                               

                8.10 Diagenode, Inc.                                      

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  1. North America Epigenetics Market, By Product, From 2022 - 2027 (USD Million)
  2. North America Enzymes Market, By Region, From 2022 - 2027 (USD Million)
  3. North America Instruments & Consumables Market, By Region, From 2022 - 2027 (USD Million)
  4. North America KITS Market, By Region, From 2022 - 2027 (USD Million)
  5. North America Reagents Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Epigenetics Market, By Research area, From 2022 - 2027 (USD Million)
  7. North America Developmental Biology Market, By Region, From 2022 - 2027 (USD Million)
  8. North America Oncology Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Drug Delivery Market, By Region, From 2022 - 2027 (USD Million)
  10. United States Epigenetics Market, By Product, From 2022 - 2027 (USD Million)
  11. United States Epigenetics Market, By Research area, From 2022 - 2027 (USD Million)
  12. Canada Epigenetics Market, By Product, From 2022 - 2027 (USD Million)
  13. Canada Epigenetics Market, By Research area, From 2022 - 2027 (USD Million)
  14. North America Epigenetics Market, By Enzymes, From 2022 - 2027 (USD Million)
  15. North America DNA-Modifying Enzymes Market, By Region, From 2022 - 2027 (USD Million)
  16. North America Protein-Modifying Enzymes Market, By Region, From 2022 - 2027 (USD Million)
  17. North America RNA-Modifying Enzymes Market, By Region, From 2022 - 2027 (USD Million)
  18. United States Epigenetics Market, By Enzymes, From 2022 - 2027 (USD Million)
  19. Canada Epigenetics Market, By Enzymes, From 2022 - 2027 (USD Million)
  20. North America Epigenetics Market, By Instruments & Consumables, From 2022 - 2027 (USD Million)
  21. North America Mass Spectrometers Market, By Region, From 2022 - 2027 (USD Million)
  22. North America Next-Generation Sequencers Market, By Region, From 2022 - 2027 (USD Million)
  23. North America QPCR Market, By Region, From 2022 - 2027 (USD Million)
  24. North America Sonicators Market, By Region, From 2022 - 2027 (USD Million)
  25. North America Others Market, By Region, From 2022 - 2027 (USD Million)
  26. United States Epigenetics Market, By Instruments & Consumables, From 2022 - 2027 (USD Million)
  27. Canada Epigenetics Market, By Instruments & Consumables, From 2022 - 2027 (USD Million)
  28. North America Epigenetics Market, By KITS, From 2022 - 2027 (USD Million)
  29. North America Bisulfite Conversion KITS Market, By Region, From 2022 - 2027 (USD Million)
  30. North America Chip-Sequence KITS Market, By Region, From 2022 - 2027 (USD Million)
  31. North America RNA Sequencing KITS Market, By Region, From 2022 - 2027 (USD Million)
  32. North America Whole-Genome Amplification KITS Market, By Region, From 2022 - 2027 (USD Million)
  33. North America 5-HMC and 5-MC Analysis KITS Market, By Region, From 2022 - 2027 (USD Million)
  34. North America Others Market, By Region, From 2022 - 2027 (USD Million)
  35. United States Epigenetics Market, By KITS, From 2022 - 2027 (USD Million)
  36. Canada Epigenetics Market, By KITS, From 2022 - 2027 (USD Million)
  37. North America Epigenetics Market, By Reagent, From 2022 - 2027 (USD Million)
  38. North America Antibodies Market, By Region, From 2022 - 2027 (USD Million)
  39. North America buffers Market, By Region, From 2022 - 2027 (USD Million)
  40. North America Histones Market, By Region, From 2022 - 2027 (USD Million)
  41. North America Magnetic Beads Market, By Region, From 2022 - 2027 (USD Million)
  42. North America Primers Market, By Region, From 2022 - 2027 (USD Million)
  43. North America Others Market, By Region, From 2022 - 2027 (USD Million)
  44. United States Epigenetics Market, By Reagent, From 2022 - 2027 (USD Million)
  45. Canada Epigenetics Market, By Reagent, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample